s6y
Company name or ticker
Search
Tempest Therapeutics, Inc.
4
Versant Ventures IV, LLC: Statement of changes in beneficial ownership of securities
Filed
Tuesday, May 3, 2022
Period
Apr 29, 2022
Accession number
0000899243-22-016383
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header